Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |